AI reads CT scans to outsmart pancreatic disease misdiagnosis
NCT ID NCT07439757
First seen Mar 14, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This study tests an artificial intelligence system that analyzes contrast-enhanced CT scans to help doctors decide the best next step for people with suspected pancreatic diseases. The AI will classify patients into three groups: immediate treatment, close monitoring, or routine follow-up. Researchers will compare the AI's recommendations to those of experienced doctors to see if it can improve accuracy and reduce unnecessary surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Changhai Hospital
RECRUITINGShanghai, 200433, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.